{"schema_version":"secwatch.filing_event.v1","accession":"0000066740-24-000023","form_type":"8-K","ticker":"MMM","cik":"0000066740","company_name":"3M CO","filed_at":"2024-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.680555+00:00","generated_at":"2026-06-05T00:53:57.460175+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"3M board approves spin-off of Health Care business as Solventum; distribution April 1, 2024","bullets":["Record date March 18, 2024; shareholders receive 1 Solventum share for every 4 MMM shares.","80.1% of Solventum distributed; 3M retains 19.9% to be monetized within 5 years.","Solventum (SOLV) to list on NYSE; when-issued trading begins March 26, 2024.","Solventum had $8.2B revenue in 2023; Bryan Hanson CEO, Wayde McMillan CFO, Carrie Cox Chair.","Spin-off intended to be tax-free to 3M shareholders; conditions remain subject to satisfaction."],"urls":{"canonical":"https://secwatch.observer/filing/0000066740-24-000023","json":"https://secwatch.observer/filing/0000066740-24-000023.json","markdown":"https://secwatch.observer/filing/0000066740-24-000023.md","text":"https://secwatch.observer/filing/0000066740-24-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/66740/000006674024000023/0000066740-24-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/66740/000006674024000023/mmm-20240308.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T00:53:57.460175+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}